ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2702

Tissue-Invasive T Cells in Rheumatoid Arthritis

Cornelia M. Weyand1, Yi Shen2, Yinyin Li1, Eric L. Matteson3, Stuart Goodman4 and Jorg Goronzy5, 1Medicine: Immunology and Rheumatology, Stanford University, Stanford, CA, 2Medicine: Immunology and Rheumatology, Stanford University School of Medicine, Stanford, CA, 3Rheumatology, Mayo Clinic College of Medicine and Science, Rochester, MN, 4Orthopaedic Surgery, Stanford Medical Center Outpatient Clinic, Redwood City, CA, 5Medicine/Division of Immunology & Rheumatology, Stanford University School of Medicine, Stanford, CA

Meeting: 2017 ACR/ARHP Annual Meeting

Date of first publication: September 18, 2017

Keywords: Immunotherapy, Inflammation, lipids and metabolism, T cells

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 7, 2017

Title: T Cell Biology and Targets in Autoimmune Disease Poster II

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: A key pathogenic event in rheumatoid arthritis (RA) is the formation of lasting lymphoid microstructures in the synovial tissue. It requires the transmigration of T cells from blood vessels into the tissue and the maneuvering of such T cells through the tissue matrix. T cells move in the tissue microenvironment by assembling cell membrane extensions, so-called podosomes. Regulation of podosome formation in T cells from RA patients is unexplored.

Methods: CD4 T cells were isolated from patients with seropositive RA and age-matched healthy controls. Tissue-residing T cells were examined in synovial biopsies. T cell motility was tested in 3D-collagen gels and in vivo by measuring T cell invasion into synovial tissue in a human synovium-SCID chimera model. Cellular metabolism of T cells was evaluated by quantifying stores of pyruvate, ATP, acetyl-CoA, and neutral fatty acids. We defined a module of 10 genes involved in regulation of the actin cytoskeleton and podosome formation, which was analyzed by RT-PCR, flow cytometry and immunohistochemistry.

Results: Compared to age-matched controls, RA T cells were high expressers of the Tyrosine Kinase Substrate with Five SH3 Domains (TKS5), an adaptor molecule critically involved in podosome formation, migrated more efficiently through 3D-gels and rapidly invaded into synovial tissues. TKS5 overexpression was sufficient to render T cells tissue-invasive; TKS5 knockdown abrogated the tissue-invasive behavior of RA T cells. TKS5 overexpression was associated with arthritogenic effector functions in the synovial tissue site, was regulated as part of a motility gene module and was found to be under metabolic control. Specifically, dampened glycolytic flux, resulting in low cellular pyruvate and ATP, induced TKS5 production and enhanced T cell hypermobility. T cells responded to energy deprivation with the accumulation of cytoplasmic lipid droplets, a prominent feature of tissue-resident synovial T cells. Restoring pyruvate stores or inhibiting fatty acid synthesis was sufficient to correct for the hypermobility of RA T cells in vitro and in vivo.

Conclusion: Synovial tissue invasion and arthritogenic T cell effector functions in RA patients are associated with dysregulated membrane function, specifically the formation of tissue-invasive podosomes. Defects in the T cell locomotion program are mechanistically linked to metabolic reprogramming, which diverts RA T cells from energy production to synthetic and proliferative functions. Understanding tissue invasiveness of RA T cells provides new opportunities to interfere with T cell trafficking and T cell invasion into specific tissue sites.


Disclosure: C. M. Weyand, None; Y. Shen, None; Y. Li, None; E. L. Matteson, None; S. Goodman, None; J. Goronzy, None.

To cite this abstract in AMA style:

Weyand CM, Shen Y, Li Y, Matteson EL, Goodman S, Goronzy J. Tissue-Invasive T Cells in Rheumatoid Arthritis [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/tissue-invasive-t-cells-in-rheumatoid-arthritis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2017 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/tissue-invasive-t-cells-in-rheumatoid-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology